Alison M Mackay1, Robert Buckingham1, Raymond S Schwartz1, Suzanne Hodgkinson1, Roy G Beran1, Dennis J Cordato1. 1. Southern Neurology, Kogarah, NSW, Australia (AMM, RSS, DJC); Charles Sturt University, Bathurst, NSW, Australia (AMM, RB); University of Sydney, Sydney, NSW, Australia (RSS); Department of Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia (SH, RGB, DJC); South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia (SH, RGB, DJC); Griffith University, South Bank, QLD, Australia (RGB); and Strategic Health Evaluations, Chatswood, NSW, Australia (RGB).
Abstract
BACKGROUND:Relaxation, mindfulness, social support, and education (RMSSE) have been shown to improve emotional symptoms, coping, and fatigue in multiple sclerosis (MS). Biofeedback was trialed as a psychological intervention, designed to improve self-control, in two groups of patients with MS. Both groups received RMSSE, and one group additionally received biofeedback. METHODS:Forty people with relapsing-remitting MS were recruited from three sites in Sydney, Australia. The mean disability score (Expanded Disability Status Scale; EDSS) was 2.41 ± 1.46 (95% confidence interval [CI], 1.46-3.36); the mean age in years was 45.9 ± 12.42 (95% CI, 41.92-49.87). Participants were randomly assigned to two active treatment groups (n = 20 per group). All participants received one 1-hour session per week for 3 weeks of RMSSE, while biofeedback equipment measured breathing rate and muscle tension. Members of one group used biofeedback screens to regulate physiological response. RESULTS: Whole-group pre- and post-treatment scores demonstrated a reduction of 38% for anxiety and 39% for depression scores (P = .007 and P = .009, respectively). A post-treatment comparison failed to demonstrate any significant difference between the two active treatment groups in anxiety and depression scores. The biofeedback group showed significant pre- to post-treatment improvement or trends toward improvement in anxiety, fatigue, and stress (P = .05, .02, and .03, respectively). Comparison of pre-post treatment results between groups showed improvements for the biofeedback group in breathing rate and muscle tension (P = .06 and .09). CONCLUSIONS: For relapsing-remitting MS patients receiving biofeedback in addition to RMSSE, there was a demonstrable reduction in anxiety, fatigue, and stress. There was also a trend toward significant reduction of breathing rate and muscle tension in favor of biofeedback.
RCT Entities:
BACKGROUND: Relaxation, mindfulness, social support, and education (RMSSE) have been shown to improve emotional symptoms, coping, and fatigue in multiple sclerosis (MS). Biofeedback was trialed as a psychological intervention, designed to improve self-control, in two groups of patients with MS. Both groups received RMSSE, and one group additionally received biofeedback. METHODS: Forty people with relapsing-remitting MS were recruited from three sites in Sydney, Australia. The mean disability score (Expanded Disability Status Scale; EDSS) was 2.41 ± 1.46 (95% confidence interval [CI], 1.46-3.36); the mean age in years was 45.9 ± 12.42 (95% CI, 41.92-49.87). Participants were randomly assigned to two active treatment groups (n = 20 per group). All participants received one 1-hour session per week for 3 weeks of RMSSE, while biofeedback equipment measured breathing rate and muscle tension. Members of one group used biofeedback screens to regulate physiological response. RESULTS: Whole-group pre- and post-treatment scores demonstrated a reduction of 38% for anxiety and 39% for depression scores (P = .007 and P = .009, respectively). A post-treatment comparison failed to demonstrate any significant difference between the two active treatment groups in anxiety and depression scores. The biofeedback group showed significant pre- to post-treatment improvement or trends toward improvement in anxiety, fatigue, and stress (P = .05, .02, and .03, respectively). Comparison of pre-post treatment results between groups showed improvements for the biofeedback group in breathing rate and muscle tension (P = .06 and .09). CONCLUSIONS: For relapsing-remitting MS patients receiving biofeedback in addition to RMSSE, there was a demonstrable reduction in anxiety, fatigue, and stress. There was also a trend toward significant reduction of breathing rate and muscle tension in favor of biofeedback.
Authors: Kirsten van Kessel; Rona Moss-Morris; Ernest Willoughby; Trudie Chalder; Malcolm H Johnson; Elizabeth Robinson Journal: Psychosom Med Date: 2008-02-06 Impact factor: 4.312
Authors: Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde Journal: Curr Neurol Neurosci Rep Date: 2016-12 Impact factor: 5.081
Authors: Paolla Gabrielle Nascimento Novais; Karla de Melo Batista; Eliane da Silva Grazziano; Maria Helena Costa Amorim Journal: Rev Lat Am Enfermagem Date: 2016-09-01
Authors: Aung Zaw Zaw Phyo; Thibaut Demaneuf; Alysha M De Livera; George A Jelinek; Chelsea R Brown; Claudia H Marck; Sandra L Neate; Keryn L Taylor; Taylor Mills; Emily O'Kearney; Amalia Karahalios; Tracey J Weiland Journal: Front Neurol Date: 2018-04-04 Impact factor: 4.003
Authors: Kristine M Ulrichsen; Tobias Kaufmann; Erlend S Dørum; Knut K Kolskår; Geneviève Richard; Dag Alnæs; Tone J Arneberg; Lars T Westlye; Jan E Nordvik Journal: Front Psychol Date: 2016-06-23
Authors: Anthony M Harrison; Reza Safari; Tom Mercer; Federica Picariello; Marietta L van der Linden; Claire White; Rona Moss-Morris; Sam Norton Journal: Mult Scler Date: 2021-04-20 Impact factor: 6.312